ATP11C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.807650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.242380E-01
Normal-vs-Stage2
2.243800E-02
Normal-vs-Stage3
7.569500E-02
Normal-vs-Stage4
1.742390E-01
Stage1-vs-Stage2
7.970800E-01
Stage1-vs-Stage3
5.263400E-01
Stage1-vs-Stage4
9.500600E-01
Stage2-vs-Stage3
3.482400E-01
Stage2-vs-Stage4
8.930000E-01
Stage3-vs-Stage4
4.458600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.537690E-02
Normal-vs-AfricanAmerican
3.164600E-01
Normal-vs-Asian
1.589980E-02
Caucasian-vs-AfricanAmerican
3.004000E-01
Caucasian-vs-Asian
3.583400E-01
AfricanAmerican-vs-Asian
1.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.206090E-02
Normal-vs-Female
3.882100E-02
Male-vs-Female
1.390960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.490570E-01
Normal-vs-Age(41-60Yrs)
5.640000E-02
Normal-vs-Age(61-80Yrs)
1.723580E-02
Normal-vs-Age(81-100Yrs)
2.095000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.836000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.523800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.101400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.268100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.825800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.906800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.597630E-02
Normal-vs-Daily Drinker
2.740500E-03
Normal-vs-Weekly Drinker
1.436240E-02
Normal-vs-Occasional Drinker
1.663530E-02
Normal-vs-Social Drinker
9.501600E-02
Non Drinker-vs-Daily Drinker
4.546800E-01
Non Drinker-vs-Weekly Drinker
8.615400E-01
Non Drinker-vs-Occasional Drinker
8.823800E-01
Non Drinker-vs-Social Drinker
5.588800E-01
Daily Drinker-vs-Weekly Drinker
3.480200E-01
Daily Drinker-vs-Occasional Drinker
5.793600E-01
Daily Drinker-vs-Social Drinker
2.343600E-01
Weekly Drinker-vs-Occasional Drinker
7.520800E-01
Weekly Drinker-vs-Social Drinker
6.942400E-01
Occasional Drinker-vs-Social Drinker
5.159800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.177800E-01
Normal-vs-Grade 2
3.004600E-01
Normal-vs-Grade 3
3.447800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.829500E-02
Grade 1-vs-Grade 3
1.136190E-01
Grade 1-vs-Grade 4
8.177800E-01
Grade 2-vs-Grade 3
7.219600E-01
Grade 2-vs-Grade 4
3.004600E-01
Grade 3-vs-Grade 4
3.447800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.615770E-02
Normal-vs-NonDiabetic
6.578700E-03
Diabetic-vs-NonDiabetic
8.204200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.027800E-01
Normal-vs-NoPancreatitis
1.079870E-02
Pancreatitis-vs-NoPancreatitis
2.910200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.258200E-02
Normal-vs-N1
1.840100E-02
N0-vs-N1
3.445000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.336800E-03
Normal-vs-TP53-NonMutant
4.824200E-02
TP53-Mutant-vs-TP53-NonMutant
6.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
